These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Amiodarone: a unique antiarrhythmic agent. Sloskey GE Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912 [TBL] [Abstract][Full Text] [Related]
4. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias. Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121 [TBL] [Abstract][Full Text] [Related]
5. Clinical use of amiodarone. Dunn M Heart Lung; 1985 Jul; 14(4):407-11. PubMed ID: 3891691 [TBL] [Abstract][Full Text] [Related]
6. Clinical use and pharmacology of amiodarone. Heger JJ; Prystowsky EN; Miles WM; Zipes DP Med Clin North Am; 1984 Sep; 68(5):1339-66. PubMed ID: 6387328 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic actions of amiodarone. Anderson GJ Am Fam Physician; 1982 Apr; 25(4):178-80. PubMed ID: 6461234 [No Abstract] [Full Text] [Related]
8. Amiodarone in long term management of refractory cardiac tachyarrhythmias. Lubbe WF; Mercer CJ; Roche AH; Lowe JB N Z Med J; 1981 Jan; 93(676):31-5. PubMed ID: 6940024 [TBL] [Abstract][Full Text] [Related]
9. Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. Best JF; Rinkenberger R; Lynch L; Dunn M Clin Cardiol; 1986 Jun; 9(6):268-71. PubMed ID: 2424656 [TBL] [Abstract][Full Text] [Related]
10. [Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects]. Depelchin P; Schoenfeld P; Stoupel E; Degré S Rev Med Brux; 1986 Feb; 7(2):92-103. PubMed ID: 3515481 [No Abstract] [Full Text] [Related]
11. The clinical results of amiodarone in cardiac arrhythmias: optimal dosing. Singh BN; Nademanee K; Kannan R; Ikeda N Pacing Clin Electrophysiol; 1984 Jan; 7(1):109-24. PubMed ID: 6199755 [TBL] [Abstract][Full Text] [Related]
12. Ten years of experience with amiodarone. Rosenbaum MB; Chiale PA; Haedo A; Lázzari JO; Elizari MV Am Heart J; 1983 Oct; 106(4 Pt 2):957-64. PubMed ID: 6613843 [TBL] [Abstract][Full Text] [Related]
13. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429 [TBL] [Abstract][Full Text] [Related]
14. [Study of the effectiveness of cordaron in different types of arrhythmia]. Zakharov VN; Kuznetsov KK Kardiologiia; 1977 Apr; 17(4):90-3. PubMed ID: 69743 [TBL] [Abstract][Full Text] [Related]
15. [Amiodarone: pharmacology, clinical use and side effects]. Popiliev I Vutr Boles; 1985; 24(5):17-25. PubMed ID: 3911581 [No Abstract] [Full Text] [Related]
16. Amiodarone therapy for life threatening or refractory cardiac arrhythmias. Johns JA; Harper RW; Currie PJ; Federman J; Anderson ST; Pitt A Aust N Z J Med; 1983 Jun; 13(3):248-56. PubMed ID: 6579938 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Rowland E; Krikler DM Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of amiodarone. Marcus FI Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011 [No Abstract] [Full Text] [Related]
19. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Marcus FI; Fontaine GH; Frank R; Grosgogeat Y Am Heart J; 1981 Apr; 101(4):480-93. PubMed ID: 7010975 [No Abstract] [Full Text] [Related]
20. [Amiodarone and the thyroid gland: apropos of 2 cases of hypothyroidism]. Pucciarelli G; Caso P; Jacono A Clin Ter; 1978 Jan; 84(1):81-4. PubMed ID: 630815 [No Abstract] [Full Text] [Related] [Next] [New Search]